Cendana Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.99 Cr
as on 29-10-2024
- Paid Up Capital ₹ 1.00 M
as on 29-10-2024
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
About Cendana Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.99 Cr and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Anant Singh, Amar Singh, Asmita Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239UP2022PTC161589
- Company No.
161589
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2022
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cendana Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anant Singh  | Managing Director | 30-Mar-2022 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Asmita Singh | Director | 30-Mar-2022 | Current |
| Amar Singh | Director | 30-Mar-2022 | Current |
| Aasti Singh | Director | 30-Mar-2022 | Current |
Financial Performance of Cendana Pharmaceuticals.
Cendana Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cendana Pharmaceuticals?
Unlock access to Cendana Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Chandan Pharmacy LimitedActive 7 years 4 monthsAnant Singh, Amar Singh and 2 more are mutual person
Chandan Hospital LimitedActive 29 years 3 monthsAmar Singh, Asmita Singh and 1 more are mutual person
Amaranita Holdings (India) Private LimitedActive 16 years 7 monthsAnant Singh, Amar Singh and 2 more are mutual person
- Indra Diagnostic Centre And Blood Bank LimitedActive 32 years 10 months
Asmita Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cendana Pharmaceuticals?
Unlock and access historical data on people associated with Cendana Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cendana Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cendana Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
